Armbruster Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $343K | Sell |
2,670
-2,022
| -43% | -$237K | 0.05% | 108 |
|
|
2026
Q1 | $564K | Buy |
4,692
+400
| +9% | +$46.2K | 0.09% | 83 |
|
|
2025
Q4 | $452K | Hold |
4,292
| – | – | 0.08% | 94 |
|
|
2025
Q3 | $360K | Sell |
4,292
-106
| -2% | -$8.73K | 0.06% | 104 |
|
|
2025
Q2 | $348K | Buy |
4,398
+106
| +2% | +$8.43K | 0.06% | 105 |
|
|
2025
Q1 | $385K | Sell |
4,292
-121
| -3% | -$11.3K | 0.08% | 98 |
|
|
2024
Q4 | $439K | Hold |
4,413
| – | – | 0.09% | 91 |
|
|
2024
Q3 | $501K | Sell |
4,413
-417
| -9% | -$49.5K | 0.1% | 87 |
|
|
2024
Q2 | $598K | Buy |
4,830
+8
| +0.2% | +$1.03K | 0.12% | 67 |
|
|
2024
Q1 | $636K | Sell |
4,822
-85
| -2% | -$10.5K | 0.14% | 61 |
|
|
2023
Q4 | $535K | Hold |
4,907
| – | – | 0.12% | 65 |
|
|
2023
Q3 | $505K | Sell |
4,907
-200
| -4% | -$21.6K | 0.13% | 65 |
|
|
2023
Q2 | $589K | Hold |
5,107
| – | – | 0.15% | 56 |
|
|
2023
Q1 | $543K | Hold |
5,107
| – | – | 0.14% | 58 |
|
|
2022
Q4 | $567K | Hold |
5,107
| – | – | 0.15% | 57 |
|
|
2022
Q3 | $440K | Sell |
5,107
-25
| -0.5% | -$2.23K | 0.13% | 70 |
|
|
2022
Q2 | $468K | Sell |
5,132
-23
| -0.4% | -$2.04K | 0.13% | 68 |
|
|
2022
Q1 | $423K | Sell |
5,155
-200
| -4% | -$15.8K | 0.1% | 87 |
|
|
2021
Q4 | $410K | Sell |
5,355
-15
| -0.3% | -$1.2K | 0.09% | 93 |
|
|
2021
Q3 | $403K | Hold |
5,370
| – | – | 0.12% | 64 |
|
|
2021
Q2 | $418K | Sell |
5,370
-258
| -5% | -$19.2K | 0.12% | 65 |
|
|
2021
Q1 | $414K | Hold |
5,628
| – | – | 0.12% | 62 |
|
|
2020
Q4 | $439K | Buy |
5,628
+314
| +6% | +$24K | 0.15% | 56 |
|
|
2020
Q3 | $421K | Sell |
5,314
-363
| -6% | -$28.4K | 0.16% | 50 |
|
|
2020
Q2 | $419K | Buy |
5,677
+352
| +7% | +$26.5K | 0.17% | 49 |
|
|
2020
Q1 | $391K | Hold |
5,325
| – | – | 0.18% | 50 |
|
|
2019
Q4 | $462K | Hold |
5,325
| – | – | 0.18% | 47 |
|
|
2019
Q3 | $428K | Hold |
5,325
| – | – | 0.18% | 46 |
|
|
2019
Q2 | $426K | Hold |
5,325
| – | – | 0.18% | 44 |
|
|
2019
Q1 | $423K | Sell |
5,325
-534
| -9% | -$39.9K | 0.18% | 47 |
|
|
2018
Q4 | $427K | Sell |
5,859
-151
| -3% | -$10.7K | 0.21% | 44 |
|
|
2018
Q3 | $407K | Buy |
6,010
+1,157
| +24% | +$73.7K | 0.18% | 48 |
|
|
2018
Q2 | $281K | Sell |
4,853
-182
| -4% | -$10.3K | 0.13% | 56 |
|
|
2018
Q1 | $262K | Sell |
5,035
-314
| -6% | -$17K | 0.12% | 57 |
|
|
2017
Q4 | $287K | Sell |
5,349
-75
| -1% | -$4.16K | 0.13% | 50 |
|
|
2017
Q3 | $331K | Sell |
5,424
-229
| -4% | -$13.9K | 0.17% | 45 |
|
|
2017
Q2 | $346K | Buy |
5,653
+189
| +3% | +$11.5K | 0.19% | 45 |
|
|
2017
Q1 | $331K | Hold |
5,464
| – | – | 0.18% | 45 |
|
|
2016
Q4 | $307K | Sell |
5,464
-221
| -4% | -$12.9K | 0.18% | 47 |
|
|
2016
Q3 | $339K | Sell |
5,685
-302
| -5% | -$17.7K | 0.21% | 44 |
|
|
2016
Q2 | $329K | Sell |
5,987
-302
| -5% | -$16.1K | 0.21% | 48 |
|
|
2016
Q1 | $318K | Sell |
6,289
-466
| -7% | -$22.8K | 0.22% | 48 |
|
|
2015
Q4 | $340K | Buy |
+6,755
| New | +$341K | 0.3% | 44 |
|
Other funds holding MRK
ECSS
Armbruster Capital Management's MRK Position: Q2 2026 in Review
Armbruster Capital Management reduced its Merck (MRK) stake by 43% in Q2 2026, selling an estimated $237K and leaving 2,670 shares worth $343K. The position accounts for 0.05% of the portfolio, ranked #108.
Armbruster Capital Management first reported a position in MRK in Q4 2015 and has held it in 43 quarters since. The position peaked at $636K in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Armbruster Capital Management held 2,670 shares of Merck worth $343K as of Q2 2026.
- Armbruster Capital Management sold 2,022 Merck shares in Q2 2026, an estimated $237K.
- Merck made up 0.05% of Armbruster Capital Management's portfolio in Q2 2026, its #108 holding.
- Armbruster Capital Management first reported a position in Merck in Q4 2015 and has held it in 43 quarters since.
- Armbruster Capital Management's Merck position peaked at $636K in Q1 2024.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Armbruster Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.